Morning Movers 02/09: (IPSU) (SPRT) (TLEO) (THOR) Higher; (DMND) (IRBT) (APRI) (TRIP) Lower
Up)
Imperial Sugar Co. (NASDAQ: IPSU) 52.6% HIGHER; reported Q1 EPS of ($0.29), versus ($0.75) reported last year. Revenue for the quarter came in at $227.68 million, versus $227.39 million reported last year.
Diamond Foods (Nasdaq: DMND) 35.9% LOWER; reports audit committee finds 2010, 2011 financials need to be restated. The company's Chairman and CEO Mendes and CFO Neil have been put on administrative leave. Since the initial release, a number of sources have said P&G (NYSE: PG) will evaluate the next steps in the sale of Pringles.
iRobot Corp. (NASDAQ: IRBT) 32.3% LOWER; reported Q4 EPS of $0.38, $0.06 better than the analyst estimate of $0.32. Revenue for the quarter came in at $130.8 million versus the consensus estimate of $134.08 million. Sees FY2012 EPS of $0.75-$0.85, versus the consensus of $1.45. Sees FY2012 revenue of $465-$485 million, versus the consensus of $529.26 million. Sees Q1 2012 EPS of $-0.08-$0.00, versus the consensus of $0.30. Sees Q1 2012 revenue of $90-$100 million, versus the consensus of $120.63 million.
Support.com, Inc. (NASDAQ: SPRT) 22% HIGHER; reported Q4 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $15 million versus the consensus estimate of $13 million.
Apricus Biosciences, Inc. (Nasdaq: APRI) 18.3% LOWER; has priced an underwritten public offering of 4,938,272 units at a price to the public of $4.05 per unit, for gross offering proceeds of $20.0 million.
Taleo (Nasdaq: TLEO) 16.9% HIGHER; Oracle (Nasdaq: ORCL) buys Taleo for $46 per share.
Tripadvisor (NASDAQ: TRIP) 16.4% LOWER; reported Q4 EPS of $0.16, vs. the analyst estimate of $0.24. Revenue for the quarter came in at $137.8 million versus the consensus estimate of $133.51 million. The stock was downgraded at Benchmark and Lazard.
Array BioPharma Inc. (NASDAQ: ARRY) 16% LOWER; announced today the pricing of an underwritten public offering of 20,000,000 primary shares of its common stock at a public offering price of $2.60 per share.
Intl Fcstone, Inc. (NASDAQ: INTL) 15% LOWER; reported Q1 EPS of ($0.02), versus $0.22 reported last year. Revenue for the quarter came in at $96.3 million, versus $96.7 million reported last year.
Thoratec Corp (NASDAQ: THOR) 13.5% HIGHER; reported Q4 EPS of $0.38, $0.05 better than the analyst estimate of $0.33. Revenue for the quarter came in at $109.4 million versus the consensus estimate of $107.56 million. Sees FY2012 EPS of $1.58-$1.68, versus the consensus of $1.65. Sees FY2012 revenue of $445-$460 million, versus the consensus of $459.3 million.
Pacer International, Inc. (NASDAQ: PACR) 12.9% LOWER; reported Q4 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $358 million versus the consensus estimate of $367.24 million. Sees FY2012 EPS of $0.35-$0.41, versus the consensus of $0.38. Sees FY2012 revenue of $1.5-$1.52 billion, versus the consensus of $1.53 billion.
A123 Systems (NASDAQ: AONE) 12.4% LOWER; Wunderlich Securities downgraded the stock from Hold to Sell, price target lowered from $3.00 to $0.50.
Groupon (NASDAQ: GRPN) 11.8% LOWER; reported Q4 EPS of ($0.02), $0.05 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $506.5 million versus the consensus estimate of $475.15 million. Sees Q1 sales of $510-$550 million, which compares to the Street estimate of $500.89 million.
Anacor Pharmaceuticals (Nasdaq: ANAC) 11.3% LOWER; today announced the sale of 3.25 million shares of its common stock for gross proceeds of $21,450,000 pursuant to an underwriting agreement with Canaccord Genuity acting as the sole bookrunner.
Furniture Brands Int'l (NYSE: FBN) 11.1% LOWER; reported Q4 EPS of ($0.17), $0.03 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $255.54 million versus the consensus estimate of $271.97 million.
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) 10.9% LOWER; reported Q4 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $11.1 million versus the consensus estimate of $12.08 million. Sees FY2012 EPS of $-0.21-$-0.14, versus the consensus of $0.02. Sees FY2012 revenue of $40-$45 million, versus the consensus of $51.72 million. The Company expects to have a net cash burn from operations of approximately $40 to $45 million in 2012.
Akamai Technologies, Inc. (NASDAQ: AKAM) 10.5% HIGHER; reported Q4 EPS of $0.45, $0.05 better than the analyst estimate of $0.40. Revenue for the quarter came in at $324 million versus the consensus estimate of $311.26 million. Expecting Q1 sales of $305-$313 million and adj-EPS of 36-39 cents. The Street is currently expecting Q1 sales of $304.82 million and EPS of 39 cents.
Aeroflex Holdings (NYSE: ARX) 10% LOWER; reported Q4 EPS of $0.15, $0.02 better than the analyst estimate of $0.13. Revenue for the quarter came in at $171.1 million versus the consensus estimate of $165.18 million. Sees Q3 2012 EPS of $0.14-$0.17, versus the consensus of $0.26. Sees Q3 2012 revenue of $167-$177 million, versus the consensus of $188.68 million. Sees FY2012 EPS of $0.73-$0.79, versus the consensus of $1.09. Sees FY2012 revenue of $700-$720 million, versus the consensus of $796.5 million.
Accuray Inc. (NASDAQ: ARAY) 9.5% HIGHER; reported Q2 EPS of ($0.10), $0.09 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $106.42 million versus the consensus estimate of $100.75 million. Sees FY2012 revenue of $400-$415 million, versus the consensus of $409.72 million.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Diamond Foods (Nasdaq: DMND) 35.9% LOWER; reports audit committee finds 2010, 2011 financials need to be restated. The company's Chairman and CEO Mendes and CFO Neil have been put on administrative leave. Since the initial release, a number of sources have said P&G (NYSE: PG) will evaluate the next steps in the sale of Pringles.
iRobot Corp. (NASDAQ: IRBT) 32.3% LOWER; reported Q4 EPS of $0.38, $0.06 better than the analyst estimate of $0.32. Revenue for the quarter came in at $130.8 million versus the consensus estimate of $134.08 million. Sees FY2012 EPS of $0.75-$0.85, versus the consensus of $1.45. Sees FY2012 revenue of $465-$485 million, versus the consensus of $529.26 million. Sees Q1 2012 EPS of $-0.08-$0.00, versus the consensus of $0.30. Sees Q1 2012 revenue of $90-$100 million, versus the consensus of $120.63 million.
Support.com, Inc. (NASDAQ: SPRT) 22% HIGHER; reported Q4 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $15 million versus the consensus estimate of $13 million.
Apricus Biosciences, Inc. (Nasdaq: APRI) 18.3% LOWER; has priced an underwritten public offering of 4,938,272 units at a price to the public of $4.05 per unit, for gross offering proceeds of $20.0 million.
Taleo (Nasdaq: TLEO) 16.9% HIGHER; Oracle (Nasdaq: ORCL) buys Taleo for $46 per share.
Tripadvisor (NASDAQ: TRIP) 16.4% LOWER; reported Q4 EPS of $0.16, vs. the analyst estimate of $0.24. Revenue for the quarter came in at $137.8 million versus the consensus estimate of $133.51 million. The stock was downgraded at Benchmark and Lazard.
Array BioPharma Inc. (NASDAQ: ARRY) 16% LOWER; announced today the pricing of an underwritten public offering of 20,000,000 primary shares of its common stock at a public offering price of $2.60 per share.
Intl Fcstone, Inc. (NASDAQ: INTL) 15% LOWER; reported Q1 EPS of ($0.02), versus $0.22 reported last year. Revenue for the quarter came in at $96.3 million, versus $96.7 million reported last year.
Thoratec Corp (NASDAQ: THOR) 13.5% HIGHER; reported Q4 EPS of $0.38, $0.05 better than the analyst estimate of $0.33. Revenue for the quarter came in at $109.4 million versus the consensus estimate of $107.56 million. Sees FY2012 EPS of $1.58-$1.68, versus the consensus of $1.65. Sees FY2012 revenue of $445-$460 million, versus the consensus of $459.3 million.
Pacer International, Inc. (NASDAQ: PACR) 12.9% LOWER; reported Q4 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $358 million versus the consensus estimate of $367.24 million. Sees FY2012 EPS of $0.35-$0.41, versus the consensus of $0.38. Sees FY2012 revenue of $1.5-$1.52 billion, versus the consensus of $1.53 billion.
A123 Systems (NASDAQ: AONE) 12.4% LOWER; Wunderlich Securities downgraded the stock from Hold to Sell, price target lowered from $3.00 to $0.50.
Groupon (NASDAQ: GRPN) 11.8% LOWER; reported Q4 EPS of ($0.02), $0.05 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $506.5 million versus the consensus estimate of $475.15 million. Sees Q1 sales of $510-$550 million, which compares to the Street estimate of $500.89 million.
Anacor Pharmaceuticals (Nasdaq: ANAC) 11.3% LOWER; today announced the sale of 3.25 million shares of its common stock for gross proceeds of $21,450,000 pursuant to an underwriting agreement with Canaccord Genuity acting as the sole bookrunner.
Furniture Brands Int'l (NYSE: FBN) 11.1% LOWER; reported Q4 EPS of ($0.17), $0.03 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $255.54 million versus the consensus estimate of $271.97 million.
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) 10.9% LOWER; reported Q4 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $11.1 million versus the consensus estimate of $12.08 million. Sees FY2012 EPS of $-0.21-$-0.14, versus the consensus of $0.02. Sees FY2012 revenue of $40-$45 million, versus the consensus of $51.72 million. The Company expects to have a net cash burn from operations of approximately $40 to $45 million in 2012.
Akamai Technologies, Inc. (NASDAQ: AKAM) 10.5% HIGHER; reported Q4 EPS of $0.45, $0.05 better than the analyst estimate of $0.40. Revenue for the quarter came in at $324 million versus the consensus estimate of $311.26 million. Expecting Q1 sales of $305-$313 million and adj-EPS of 36-39 cents. The Street is currently expecting Q1 sales of $304.82 million and EPS of 39 cents.
Aeroflex Holdings (NYSE: ARX) 10% LOWER; reported Q4 EPS of $0.15, $0.02 better than the analyst estimate of $0.13. Revenue for the quarter came in at $171.1 million versus the consensus estimate of $165.18 million. Sees Q3 2012 EPS of $0.14-$0.17, versus the consensus of $0.26. Sees Q3 2012 revenue of $167-$177 million, versus the consensus of $188.68 million. Sees FY2012 EPS of $0.73-$0.79, versus the consensus of $1.09. Sees FY2012 revenue of $700-$720 million, versus the consensus of $796.5 million.
Accuray Inc. (NASDAQ: ARAY) 9.5% HIGHER; reported Q2 EPS of ($0.10), $0.09 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $106.42 million versus the consensus estimate of $100.75 million. Sees FY2012 revenue of $400-$415 million, versus the consensus of $409.72 million.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Notable Mergers and Acquisitions of the Day 05/25: (TLB) (MSFT)/(CMCSA) (BAC)
- After-Hours Movers 05/24: (BLOX) (DLPH) (CHK) Higher; (PAY) (NYMT) (SMTC) Lower
- Streetinsider.com's Hot Lunchtime Reads 05/25: (HAS) (ADP) (EMC) (PAY)
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Lazard, Genuity Capital Markets, Morning Movers, Wunderlich SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
